• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿低度和室管膜脊髓肿瘤。

Pediatric low-grade and ependymal spinal cord tumors.

作者信息

Merchant T E, Kiehna E N, Thompson S J, Heideman R, Sanford R A, Kun L E

机构信息

Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

出版信息

Pediatr Neurosurg. 2000 Jan;32(1):30-6. doi: 10.1159/000028894.

DOI:10.1159/000028894
PMID:10765136
Abstract

Our institutional experience with pediatric spinal cord tumors includes 25 patients with the diagnosis of ependymoma (EP; n = 4), myxopapillary ependymoma (MPEP; n = 4), juvenile pilocytic astrocytoma (JPA; n = 5), nonpilocytic astrocytoma (WHO grade I or II, n = 6), and other nonastrocytic spinal cord tumors (n = 6) treated during the period 1974-1999. Nineteen patients required radiation therapy (RT). The median progression-free survival following RT was 65 months (range 1-206 months). Seven patients recurred at an average of 22 months. The EP patients recurred at an average of 8.5 months, while the patients with low-grade astrocytoma recurred at an average of 42 months. Including the 6 nonsurviving patients, the median overall survival was 96 months. Two EP patients died with a progression-free survival of 9 months. One patient with MPEP died of other causes at 7 months. The treatment of pediatric spinal cord tumors should be individualized based on the histologic type. Radical surgery is indicated for nonmyxopapillary EP and low-grade astrocytic tumors. The need for adjuvant therapy most often depends on the extent of resection as well as the tumor type. Patients with disseminated EP, MPEP, JPA and nonpilocytic astrocytoma may achieve long-term progression-free survival with craniospinal irradiation.

摘要

我们机构在小儿脊髓肿瘤方面的经验包括1974年至1999年期间治疗的25例诊断为室管膜瘤(EP;n = 4)、黏液乳头型室管膜瘤(MPEP;n = 4)、青少年毛细胞型星形细胞瘤(JPA;n = 5)、非毛细胞型星形细胞瘤(世界卫生组织I级或II级,n = 6)以及其他非星形细胞脊髓肿瘤(n = 6)的患者。19例患者需要放疗(RT)。放疗后的无进展生存期中位数为65个月(范围1 - 206个月)。7例患者复发,平均复发时间为22个月。EP患者平均8.5个月复发,而低级别星形细胞瘤患者平均42个月复发。包括6例未存活患者,总生存期中位数为96个月。2例EP患者在无进展生存期9个月时死亡。1例MPEP患者在7个月时死于其他原因。小儿脊髓肿瘤的治疗应根据组织学类型个体化。对于非黏液乳头型EP和低级别星形细胞瘤,建议行根治性手术。辅助治疗的必要性通常取决于切除范围以及肿瘤类型。患有播散性EP、MPEP、JPA和非毛细胞型星形细胞瘤的患者通过全脑全脊髓照射可能实现长期无进展生存。

相似文献

1
Pediatric low-grade and ependymal spinal cord tumors.小儿低度和室管膜脊髓肿瘤。
Pediatr Neurosurg. 2000 Jan;32(1):30-6. doi: 10.1159/000028894.
2
Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases.髓内脊髓肿瘤切除术后无进展生存期和长期神经学转归的相关因素:101例连续病例分析
J Neurosurg Spine. 2009 Nov;11(5):591-9. doi: 10.3171/2009.4.SPINE08159.
3
Outcome of children with primary intramedullary spinal cord tumors.原发性脊髓髓内肿瘤患儿的预后。
Childs Nerv Syst. 1987;3(2):89-92. doi: 10.1007/BF00271131.
4
Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database.儿童和青少年脊髓室管膜瘤:来自HIT数据库的回顾性系列研究
J Neurosurg Pediatr. 2010 Aug;6(2):137-44. doi: 10.3171/2010.5.PEDS09553.
5
Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.脊髓室管膜瘤的手术结果以及儿童和青年患者中肿瘤切除范围的重要性。
J Neurosurg Pediatr. 2014 Apr;13(4):393-9. doi: 10.3171/2013.12.PEDS13383. Epub 2014 Feb 7.
6
Intramedullary spinal cord ependymoma and astrocytoma: intraoperative frozen-section diagnosis, extent of resection, and outcomes.脊髓髓内室管膜瘤和星形细胞瘤:术中冰冻切片诊断、切除范围及预后
J Neurosurg Spine. 2018 Oct 19;30(1):133-139. doi: 10.3171/2018.7.SPINE18230. Print 2019 Jan 1.
7
A systematic review of outcome in intramedullary ependymoma and astrocytoma.髓内室管膜瘤和星形细胞瘤结局的系统评价
J Clin Neurosci. 2019 May;63:168-175. doi: 10.1016/j.jocn.2019.02.001. Epub 2019 Mar 2.
8
Spinal cord gliomas: management and outcome with reference to adjuvant therapy.脊髓胶质瘤:参考辅助治疗的管理与预后
J Clin Neurosci. 2000 Jan;7(1):20-3. doi: 10.1054/jocn.1999.0128.
9
Management and outcome in adult intramedullary spinal cord tumours: a 20-year single institution experience.成人脊髓髓内肿瘤的管理与预后:一项长达20年的单机构经验
BMC Res Notes. 2014 Dec 15;7:908. doi: 10.1186/1756-0500-7-908.
10
The clinical features and surgical outcomes of pediatric patients with primary spinal cord tumor.原发性脊髓肿瘤患儿的临床特征及手术结果
Childs Nerv Syst. 2012 Jun;28(6):897-904. doi: 10.1007/s00381-012-1718-8. Epub 2012 Mar 25.

引用本文的文献

1
Survival Patterns and Mortality Causes in Patients with Invasive Ependymoma: A Retrospective Cohort Analysis from 2000 to 2019.侵袭性室管膜瘤患者的生存模式和死亡原因:一项2000年至2019年的回顾性队列分析
Med Sci (Basel). 2025 Aug 16;13(3):139. doi: 10.3390/medsci13030139.
2
Optimizing outcomes in intracranial ependymoma: a contemporary review.优化颅内室管膜瘤的治疗结果:当代综述
Front Oncol. 2025 Jun 10;15:1617169. doi: 10.3389/fonc.2025.1617169. eCollection 2025.
3
Clinical management and prognosis of spinal myxopapillary ependymoma: a single-institution cohort of 72 patients.
脊髓黏液乳头型室管膜瘤的临床治疗与预后:单中心 72 例患者队列研究。
Eur Spine J. 2023 Jul;32(7):2459-2467. doi: 10.1007/s00586-023-07690-9. Epub 2023 Apr 7.
4
Current management in the treatment of intramedullary ependymomas in children.儿童髓内室管膜瘤的当前治疗管理
Childs Nerv Syst. 2023 May;39(5):1183-1192. doi: 10.1007/s00381-022-05814-y. Epub 2022 Dec 27.
5
Ependymoma, NOS and anaplastic ependymoma incidence and survival in the United States varies widely by patient and clinical characteristics, 2000-2016.2000 - 2016年,美国NOS级室管膜瘤和间变性室管膜瘤的发病率及生存率因患者和临床特征的不同而有很大差异。
Neurooncol Pract. 2020 May 9;7(5):549-558. doi: 10.1093/nop/npaa023. eCollection 2020 Oct.
6
Evaluating pediatric spinal low-grade gliomas: a 30-year retrospective analysis.评估小儿脊髓低度神经胶质瘤:30 年回顾性分析。
J Neurooncol. 2019 Dec;145(3):519-529. doi: 10.1007/s11060-019-03319-4. Epub 2019 Oct 22.
7
Factors associated with postoperative outcomes in patients with intramedullary Grade II ependymomas: A Systematic review and meta-analysis.髓内二级室管膜瘤患者术后结局的相关因素:一项系统评价和荟萃分析。
Medicine (Baltimore). 2019 Jun;98(25):e16185. doi: 10.1097/MD.0000000000016185.
8
Pediatric Spinal Ependymomas.小儿脊髓室管膜瘤。
Med Sci Monit. 2018 Oct 5;24:7072-7089. doi: 10.12659/MSM.910447.
9
Outcome predictors in the management of intramedullary classic ependymoma: An integrative survival analysis.髓内经典型室管膜瘤治疗的预后预测因素:一项综合生存分析
Medicine (Baltimore). 2018 Jun;97(23):e10870. doi: 10.1097/MD.0000000000010870.
10
The influence of central review on outcome in malignant gliomas of the spinal cord: the CCG-945 experience.中央审查对脊髓恶性胶质瘤预后的影响:CCG - 945研究经验
J Neurosurg Pediatr. 2016 Apr;17(4):453-9. doi: 10.3171/2015.10.PEDS1581. Epub 2015 Dec 18.